Why Rockwell Medical Inc. Shares Dipped

Rockwell Medical shares hit the deck after the company reports a wider net loss than expected. Find out what investors should really have their eyes on instead.

May 13, 2014 at 1:46PM

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Rockwell Medical (NASDAQ:RMTI), a biopharmaceutical company focused on developing therapies to treat end-stage renal disease and chronic kidney disease, fell as much as 10% after the company reported its first-quarter earnings results after the closing bell last night.

So what: For the quarter, Rockwell Medical reported revenue of $13 million, a 5% increase over the year-ago quarter, as gross profit jumped 31%, to $1.7 million, and research and development expenses tumbled 64%, to just $4.6 million. The company's net loss for the quarter was practically halved, down 49%, to $7.8 million, or $0.20 per share, from $15.4 million, or $0.72 per share in Q1 2013. By comparison, Wall Street was anticipating a narrower net loss of just $0.14 per share.

Now what: While Rockwell didn't go into a lot of detail about its earnings results, the only factor that really had a demonstrable change was its reduced R&D expenses with the absence of its Triferic trial costs. While investors might feel enticed to duck and cover based on today's wider loss, they should really be focused on the outcome of Rockwell's new drug application filing for Triferic as an iron replacement therapy during dialysis. Triferic performed remarkably well in trials, and my personal expectation is that it'll be approved by the Food and Drug Administration. With annual peak sales expected to be $150 million-$250 million for Triferic (if approved), and the company's costs coming down considerably, I suspect there could be decent upside in shares over the long run following today's swoon.

Rockwell Medical may have plenty of potential, but even if could struggle to keep pace with this top stock over the long run
Give me five minutes, and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer handpicks one stock with outstanding potential. But it's not just any run-of-the-mill company; it’s a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year, his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252%, and 1,303% during the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information